BBOT vs BMBL · rev $7.5M vs rev $422.9M
BridgeBio Oncology Therapeutics, Inc. (BBOT) versus Bumble Inc (BMBL) — a side-by-side from cached financials, not a winner call.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Bumble Inc (BMBL) is a internet content & information company listed on US.
Latest reported BBOT revenue for 2026-06-30 was $7.5M. Net income was -$98.6M. Revenue was up 90.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
Latest reported BMBL revenue for 2026-06-30 was $422.9M. Net income was -$64.8M. Revenue was up 99.1% from 2026-03-31 to 2026-06-30. BMBL currently screens at market cap $974.7M.
BBOT currently screens at market cap $610.4M. BMBL currently screens at market cap $974.7M.
Not investment advice. Open the BBOT and BMBL stock pages for the full models.
Not investment advice.